When you’re living with a rare disease like intermediate or high-risk myelofibrosis (MF), the path you
take to move your treatment journey forward depends on your individual condition as well as the
decisions you make with your Healthcare Professional.
Discover what’s possible with Jakafi®—the first and only prescription medicine approved by the FDA
for people with intermediate or high-risk MF.
Clinical studies showed that Jakafi helped some patients:
• Reduce spleen size
• Improve the core symptoms of MF, including: night sweats, itching, bone/muscle
pain, abdominal discomfort, pain under the left ribs and an early feeling of fullness
Two clinical studies have been conducted with Jakafi and patients with MF. In an additional analysis
of one of the trials, some patients taking Jakafi experienced improvement in their fatigue-
related MF symptoms and in the associated impacts of fatigue on their daily activities (i.e., work,
self-care, and exercise).
Fatigue-related MF symptoms included:
Tiredness | Exhaustion | Mental tiredness | Lack of energy
How your MF progresses and how you may respond to Jakafi depends on your specific circumstances.
Your individual results may vary. Please read the Important Safety Information for Jakafi to
the right and discuss any questions you have with your Healthcare Professional. Only your
Healthcare Professional can determine if Jakafi is right for you.
Move your journey in the direction that’s right for you
FOR PEOPLE WITH INTERMEDIATE OR HIGH-RISK MYELOFIBROSIS
Discover Your Path to Possible
If you and your Healthcare Professional decide that Jakafi is right for you, the oncology certified
nurses of IncyteCARES can help eligible patients* understand their insurance coverage and financial
assistance options, as well as provide ongoing education and support resources. Learn more at
IncyteCARES: Connecting to Access, Reimbursement, Education and Support
*Terms and conditions apply.
Discover what’s possible for you.
Talk with your Healthcare Professional about Jakafi today.